We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Linda H. Lee is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2009 — 2011 |
Lee, Linda |
F31Activity Code Description: To provide predoctoral individuals with supervised research training in specified health and health-related areas leading toward the research degree (e.g., Ph.D.). |
Astrocytes and Physiological Amyloid-Beta Signaling. @ Columbia University Health Sciences
DESCRIPTION (provided by applicant): Amyloid-[unreadable] (A[unreadable]) is a peptide that is produced and secreted by neurons throughout life via mechanisms that are regulated by synaptic activity. A[unreadable] peptides have been extensively studied as the pathological plaque-forming protein species in Alzheimer's Disease. However, the normal physiological role(s) and target(s) of A[unreadable] peptides are currently unknown. When physiologically relevant (picomolar) amounts of A[unreadable] peptides are applied to acute hippocampal slices or directly in-vivo, synaptic plasticity and memory are enhanced in mice via a process that is dependent on the a7 nicotinic acetylcholine receptor (a7-nAChR). Astrocytes, as crucial glial support cells and participants in synaptic transmission, are likely candidates for mediating A[unreadable] signaling. I hypothesize that similar to what has been found for other signaling molecules, astrocytes may sense neuronal A[unreadable] release at the synapse and respond with "gliotransmitter" exocytosis which can produce neuromodulation. A possible molecular candidate in this pathway is the a7-nAChR, which is expressed by neurons and glia and can be directly bound or affected by AP42 peptides with high picomolar affinity. Furthermore, in astrocytes, a7-nAChR activation elevates intracellular calcium levels and can result in glutamate release. Thus, a7-nAChRs are well-poised to be a molecular link between A[unreadable] signaling and astrocyte-mediated neuromodulation. To investigate this hypothesis using hippocampal cell culture systems (which enable direct manipulation of constituent cellular populations), the following aims will be addressed. Aim 1: The effects of picomolar amounts of A[unreadable] peptides on the intracellular calcium signaling dynamics of astrocytes will examined with calcium dye imaging on astrocyte cultures. The involvement of a7-nAChRs will be tested using pharmacological compounds and an a7 subunit knockout mouse model. Aim 2: The astrocytic output in response to A[unreadable] peptides will be examined with a glutamate gliotransmitter assay involving "biosensor" sniffer cells for fine temporal and spatial resolution. Aim 3: The effects of picomolar A[unreadable] peptides on neurotransmission and synaptic plasticity in neuron-glia mixed cultures will be analyzed using patch-clamp technique. To determine the role of astrocytic a7-nAChRs, these experiments will be concurrently done on mixed cultures of wild-type neurons plated on a7 subunit knockout astrocytes. Considering the huge clinical significance and large amount of Alzheimer's Disease research that is being done on A[unreadable] peptides, it is highly important to discover their normal physiological roles in addition to their involvement in disease pathogenesis. An understanding of their basic functions and targets would enlighten Alzheimer's Disease research and could provide new therapeutic insights and possibilities.
|
0.915 |